Free Trial

This company has been marked as potentially delisted and may not be actively trading.

Recro Pharma (REPH) News Today

Recro Pharma logo

REPH Latest News

Fuji Pharma Co. Ltd.
Here's what Wall Street expects from Recro Pharma's earnings report
What Wall Street expects from Recro Pharma's earnings
Mankind Pharma Ltd (MNKI)
Societal CDMO Inc
Is Recro Pharma (REPH) a Worthy Investment?
Recap: Recro Pharma Q4 Earnings
Recro Signs Renewable Energy Agreement With Georgia Power
Recro Pharma (REPH) Moves to Buy: Rationale Behind the Upgrade
Recro Pharma is about to announce its earnings — here's what to expect
Recro Pharma Inc hosts conference call for investors
Get Recro Pharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for REPH and its competitors with MarketBeat's FREE daily newsletter.

REPH Media Mentions By Week

REPH Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

REPH
News Sentiment

0.00

0.58

Average
Medical
News Sentiment

REPH News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

REPH Articles
This Week

0

0

REPH Articles
Average Week

Get Recro Pharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for REPH and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:REPH) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners